Harbert Fund Advisors’s Boston Scientific BSX Stock Holding History

Harbert Fund Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,750	Closed	-$1.08M	–	22
2025 Q1	$1.08M	Sell	10,750 -6,750	-39%	-$680K	1.23%	35
2024 Q4	$1.56M	Buy	17,500 +2,500	+17%	+$220K	0.81%	37
2024 Q3	$1.26M	Buy	15,000 +8,475	+130%	+$668K	0.74%	38
2024 Q2	$502K	Sell	6,525 -8,475	-57%	-$620K	0.36%	70
2024 Q1	$1.03M	Sell	15,000 -17,500	-54%	-$1.13M	0.71%	37
2023 Q4	$1.88M	Buy	32,500 +22,500	+225%	+$1.2M	1.29%	22
2023 Q3	$528K	Sell	10,000 -22,500	-69%	-$1.18M	0.38%	39
2023 Q2	$1.76M	Sell	32,500 -17,500	-35%	-$914K	0.99%	36
2023 Q1	$2.5M	Buy	50,000 +21,100	+73%	+$994K	1.65%	26
2022 Q4	$1.34M	Sell	28,900 -41,100	-59%	-$1.78M	1.07%	34
2022 Q3	$2.71M	Buy	70,000 +48,250	+222%	+$1.94M	1.44%	20
2022 Q2	$811K	Buy	+21,750	New	+$885K	0.39%	40

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Harbert Fund Advisors's BSX Position: Q2 2025 in Review

Harbert Fund Advisors sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 10,750 shares — an estimated $1.08M sold.

Harbert Fund Advisors first reported a position in BSX in Q2 2022 and held it in 12 quarters. The position peaked at $2.71M in Q3 2022. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Harbert Fund Advisors reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Harbert Fund Advisors sold 10,750 Boston Scientific shares in Q2 2025, an estimated $1.08M.
Harbert Fund Advisors first reported a position in Boston Scientific in Q2 2022 and held it in 12 quarters.
Harbert Fund Advisors's Boston Scientific position peaked at $2.71M in Q3 2022.
1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Harbert Fund Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.